Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

RetinalGenix Technologies Inc.

retinalgenix.com
Filed: May 20, 2026 CIK: 0001836295Biotechnology
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

RetinalGenix Technologies faces immediate financial distress with only $180 cash versus $2.5M liabilities and substantial doubt about going concern status. Despite raising $125K in May 2026, the company reports inadequate resources to fund operations beyond the next few days, creating extreme near-term viability risk.

Red Flags Detected (6)

Only $180 cash on hand as of March 31, 2026 with $2.56M in liabilities

Inadequate resources to fund operations beyond next few days despite recent $125K funding

Substantial doubt about ability to continue as a going concern

3 more red flags detected

Key Takeaways

Company is in severe financial distress requiring immediate capital infusion

No commercial revenue despite being founded in 2017 and developing ophthalmic devices

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 20, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence95%
Red Flags6

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings